Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takehiro Takahashi

Showing results (91-100 of 134) with videos related to

Pageof 14
Sort By:
Clinical Rheumatology|September 18, 2012
Increased circulating fibrinogen-like protein 2 in patients with systemic sclerosisKoichi Yanaba, Yoshihide Asano, Shinji Noda, et al.
The Journal of Experimental Medicine|February 25, 2017
Epithelial Fli1 deficiency drives systemic autoimmunity and fibrosis: Possible roles in sclerodermaTakehiro Takahashi, Yoshihide Asano, Koji Sugawara, et al.
Acta Dermato-Venereologica|September 3, 2013
Serum angiopoietin-like protein 3 levels: possible correlation with progressive skin sclerosis, digital ulcers and pulmonary vascular involvement in patients with systemic sclerosisYohei Ichimura, Yoshihide Asano, Kaname Akamata, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 7, 2020
Altered Properties of Endothelial Cells and Mesenchymal Stem Cells Underlying the Development of Scleroderma-like Vasculopathy in KLF5<sup>+/-</sup> ;Fli-1<sup>+/-</sup> MiceKouki Nakamura, Takashi Taniguchi, Megumi Hirabayashi, et al.
Archives of Dermatological Research|October 12, 2012
Increased production of soluble inducible costimulator in patients with diffuse cutaneous systemic sclerosisKoichi Yanaba, Yoshihide Asano, Shinji Noda, et al.
Rheumatology (Oxford, England)|January 5, 2013
Decreased cathepsin V expression due to Fli1 deficiency contributes to the development of dermal fibrosis and proliferative vasculopathy in systemic sclerosisShinji Noda, Yoshihide Asano, Takehiro Takahashi, et al.
Archives of Dermatological Research|December 13, 2012
Clinical significance of serum soluble Tie1 levels in patients with systemic sclerosisShinji Noda, Yoshihide Asano, Naohiko Aozasa, et al.
Archives of Dermatological Research|October 18, 2017
A possible implication of reduced levels of LIF, LIFR, and gp130 in vasculopathy related to systemic sclerosisTakashi Taniguchi, Takuya Miyagawa, Zenshiro Tamaki, et al.
The Journal of Dermatology|April 23, 2017
Serum H-ficolin levels: Clinical association with interstitial lung disease in patients with systemic sclerosisTakuya Miyagawa, Yoshihide Asano, Yuka de Mestier, et al.
Rheumatology (Oxford, England)|February 28, 2013
A possible contribution of visfatin to the resolution of skin sclerosis in patients with diffuse cutaneous systemic sclerosis via a direct anti-fibrotic effect on dermal fibroblasts and Th1 polarization of the immune responseYuri Masui, Yoshihide Asano, Sayaka Shibata, et al.
Pageof 14

Showing results (91-100 of 134) with videos related to

Sort By:
Pageof 14
Clinical Rheumatology|September 18, 2012
Increased circulating fibrinogen-like protein 2 in patients with systemic sclerosisKoichi Yanaba, Yoshihide Asano, Shinji Noda, et al.
The Journal of Experimental Medicine|February 25, 2017
Epithelial Fli1 deficiency drives systemic autoimmunity and fibrosis: Possible roles in sclerodermaTakehiro Takahashi, Yoshihide Asano, Koji Sugawara, et al.
Acta Dermato-Venereologica|September 3, 2013
Serum angiopoietin-like protein 3 levels: possible correlation with progressive skin sclerosis, digital ulcers and pulmonary vascular involvement in patients with systemic sclerosisYohei Ichimura, Yoshihide Asano, Kaname Akamata, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 7, 2020
Altered Properties of Endothelial Cells and Mesenchymal Stem Cells Underlying the Development of Scleroderma-like Vasculopathy in KLF5<sup>+/-</sup> ;Fli-1<sup>+/-</sup> MiceKouki Nakamura, Takashi Taniguchi, Megumi Hirabayashi, et al.
Archives of Dermatological Research|October 12, 2012
Increased production of soluble inducible costimulator in patients with diffuse cutaneous systemic sclerosisKoichi Yanaba, Yoshihide Asano, Shinji Noda, et al.
Rheumatology (Oxford, England)|January 5, 2013
Decreased cathepsin V expression due to Fli1 deficiency contributes to the development of dermal fibrosis and proliferative vasculopathy in systemic sclerosisShinji Noda, Yoshihide Asano, Takehiro Takahashi, et al.
Archives of Dermatological Research|December 13, 2012
Clinical significance of serum soluble Tie1 levels in patients with systemic sclerosisShinji Noda, Yoshihide Asano, Naohiko Aozasa, et al.
Archives of Dermatological Research|October 18, 2017
A possible implication of reduced levels of LIF, LIFR, and gp130 in vasculopathy related to systemic sclerosisTakashi Taniguchi, Takuya Miyagawa, Zenshiro Tamaki, et al.
The Journal of Dermatology|April 23, 2017
Serum H-ficolin levels: Clinical association with interstitial lung disease in patients with systemic sclerosisTakuya Miyagawa, Yoshihide Asano, Yuka de Mestier, et al.
Rheumatology (Oxford, England)|February 28, 2013
A possible contribution of visfatin to the resolution of skin sclerosis in patients with diffuse cutaneous systemic sclerosis via a direct anti-fibrotic effect on dermal fibroblasts and Th1 polarization of the immune responseYuri Masui, Yoshihide Asano, Sayaka Shibata, et al.
Pageof 14